Search
Entrada Therapeutics Inc
TRDAAdd to Watchlist
7.488USD
-0.252-3.25%
Market hours （ET）Quotes delayed by 15 min
286.68MMarket Cap
LossP/E TTM
Entrada Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-26The current valuation score of Entrada Therapeutics Inc is 7.01, ranking 271 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.93, which is -1305.83% below the recent high of 23.32 and -4245.26% above the recent low of -84.05.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
